Biggest flu outbreak in 25 years hits Japan
Japan in the last week of December experienced the biggest influenza outbreak since comparable data became available 25 years ago, health authorities said Thursday.
Read More
Stimulant users are caught in fatal ‘fourth wave’ of opioid epidemic
In Pawtucket, Rhode Island, near a storefront advertising “free” cellphones, J.R. sat in an empty back stairwell and showed a reporter how he tries to avoid overdosing when he smokes crack cocaine. KFF Health News is identifying him by his initials because he fears being arrested for using illegal drugs.
Researchers enhance automated method to detect common sleep disorder affecting millions
A Mount Sinai-led team of researchers has enhanced an artificial intelligence (AI)-powered algorithm to analyze video recordings of clinical sleep tests, ultimately improving accurate diagnosis of a common sleep disorder affecting more than 80 million people worldwide.
ORACLE lung cancer test predicts survival in early stages better than current methods
Researchers at the Francis Crick Institute, the UCL Cancer Institute and UCLH have shown that a test called ORACLE can predict lung cancer survival at the point of diagnosis better than currently used clinical risk factors. This could help doctors make more informed treatment decisions for people with stage 1 lung cancer, potentially reducing the risk of the cancer returning or spreading.
Dementia diagnosis: How long do patients really live?
The average life expectancy of people diagnosed with dementia ranges from nine years at age 60 to 4.5 years at age 85 for women and from 6.5 to just over two years, respectively, in men, finds a systematic review of the latest evidence in The BMJ.
Health insurers limit coverage of prosthetic limbs, questioning their medical necessity
When Michael Adams was researching health insurance options in 2023, he had one very specific requirement: coverage for prosthetic limbs.
Extended nirmatrelvir/ritonavir found to be beneficial for some with long COVID
Extended-course nirmatrelvir/ritonavir yields a meaningful reduction in symptoms for some patients with long COVID, but not all benefits persist, according to a case series published online Jan. 6 in Communications Medicine.
Study finds 1 in 4 older U.S. veterans report cardiovascular disease diagnosis
One in four older U.S. veterans report being diagnosed with cardiovascular disease (CVD) in their lifetime, according to a study published online Dec. 18 in PLOS Mental Health.
Research shows 8 in 10 infants received RSV protection in the 2023 to 2024 season
Eight in 10 infants received respiratory syncytial virus (RSV) protection during the 2023 to 2024 season, according to a research letter published online Jan. 8 in JAMA Network Open.
Cadrenal Therapeutics to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025
PONTE VEDRA, Fla.–(BUSINESS WIRE)–Cadrenal Therapeutics, Inc., (Nasdaq: CVKD), today announced that Chairman and Chief Executive Officer, Quang X. Pham, will participate in a webcasted fireside chat at the Lytham Partners 2025 Investor Healthcare Summit, taking place virtually on Monday, January 13, 2025. Cadrenal Therapeutics is a biopharmaceutical company focused on developing tecarfarin, a novel oral vitamin K antagonist (VKA) in advanced clinical development and designed to be a superior